Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-06-10

FDA Approved: TIZANIDINE HYDROCHLORIDE — Supplemental Application (Alembic Pharmaceuticals Limited)

View source ↗

Summary

The FDA approved a supplemental application for a generic tizanidine hydrochloride product submitted by Alembic Pharmaceuticals Limited under ANDA213223.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tizanidine hydrochloride (Tizanidine hydrochloride)

Snippet

SUPPL AP for TIZANIDINE HYDROCHLORIDE (TIZANIDINE HYDROCHLORIDE)